Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy

BACKGROUND: While it is well known that teriparatide (TPTD) increases bone mineral density (BMD) in osteoporotic patients, it is unknown whether TPTD pretreatment affects BMD after denosumab (DMAb) therapy. METHODS: Fifty-seven patients in TPTD-pretreated group and 35 patients in DMAb-alone group ha...

Full description

Saved in:
Bibliographic Details
Published in:Ther Clin Risk Manag
Main Authors: Kamimura, Mikio, Taguchi, Akira, Nakamura, Yukio, Koiwai, Hidefumi, Ikegami, Shota, Uchiyama, Shigeharu, Kato, Hiroyuki
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2018
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5892610/
https://ncbi.nlm.nih.gov/pubmed/29662314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S154686
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items